Australia markets open in 9 hours 42 minutes

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1750+0.0100 (+6.06%)
At close: 04:10PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
30/06/2018
Operating expenses
Research development
2,735
2,495
2,760
3,682
2,057
Selling general and administrative
3,732
2,932
1,734
1,863
1,549
Total operating expenses
6,467
5,428
4,495
5,545
3,607
Operating income or loss
-6,467
-5,428
-4,495
-5,545
-3,607
Interest expense
4.19
10.615
4.19
3.301
2.2
Total other income/expenses net
1,469
1,223
1,107
1,679
909.327
Income before tax
-4,966
-4,149
-3,321
-3,797
-2,574
Income tax expense
0
0
0
0
0
Income from continuing operations
-4,966
-4,149
-3,321
-3,797
-2,574
Net income
-4,966
-4,149
-3,321
-3,797
-2,574
Net income available to common shareholders
-4,966
-4,149
-3,321
-3,797
-2,574
Basic EPS
-
-0.01
-0.01
-0.02
-0.01
Diluted EPS
-
-0.01
-0.01
-0.02
-0.01
Basic average shares
-
611,805
394,261
244,545
214,012
Diluted average shares
-
611,805
394,261
244,545
214,012
EBITDA
-
-4,138
-3,316
-3,794
-2,570